In the first two experiments, an excess of leukocytes in the tumor site (Days 15–28), impeded the correct assessment of the state of tumor-associated CD11b+Ly-6G+/Ly-6C+ MDSCs not recruited (local) to the resorbing tumor due to the similarity of their superficial markers and those expressed by classically activated proinflammatory macrophages and neutrophils [12–14]. The gene discussed is ITGAM; the disease is neoplasm.